University of Kansas Cancer Center Post San Antonio Review

 

University of Kansas Cancer Center Post San Antonio Review
Avatar

Expert Discussion on Challenging BC Cases: What Treatment Option to Consider for HER2+ De-Novo mBC? What Is the Best 1L Option for T2N0 TNBC Treated With NA AC-T? Does BRCA Status Impact the Choice of Chemo Backbone for IO?

By University of Kansas Cancer Center Post San Antonio Review FEATURING Priyanka Sharma, Jennifer Klemp, Heather McArthur, Susan Domchek
By University of Kansas Cancer Center Post San Antonio Review FEATURING Priyanka Sharma, Jennifer Klemp, Heather McArthur, Susan Domchek
177 views
February 28, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
2021
14:39

What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of Oral …

University of Kansas Cancer Center Post San Antonio Review

H. McArthur

380 views
16:19

2021 Changing Treatment Paradigms for HER2+ mBC: Expert Efficacy Ana…

University of Kansas Cancer Center Post San Antonio Review

H. McArthur

198 views
14:55

50 y/o Premenopausal Woman With T2N1mic BC: Would You Order Gene Exp…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, S. Tolaney, I. Mayer, Q. Khan, J. Balko

67 views
14:05

Challenging Cases of BC: What Should Be the Next Line of Therapy for…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, S. Tolaney, I. Mayer, Q. Khan, J. Balko

320 views
12:04

48 y/o PALB2 Mutation Carrier With T2N0 ER/PR+, HER2- BC: How to Cou…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

273 views
08:29

42 y/o With cT2N Grade III TNBC: Does Inclusion of CPIs & Carboplati…

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

161 views
07:56

Expert Discussion on Challenging BC Cases: What Treatment Option to …

University of Kansas Cancer Center Post San Antonio Review

P. Sharma, J. Klemp, H. McArthur, S. Domchek

177 views
19:16

BC Predisposition Genes San Antonio Review: Who to Test? Should the …

University of Kansas Cancer Center Post San Antonio Review

S. Domchek

97 views
17:29

SABCS Updates on HR+, HER2- MBC: What Is the Role of HDACi? Does Int…

University of Kansas Cancer Center Post San Antonio Review

S. Tolaney

189 views
07:53

SABCS Data on mTNBC: 1L Chemo + IO in PD-L1+ Disease, Sacituzumab Go…

University of Kansas Cancer Center Post San Antonio Review

S. Tolaney

225 views
21:41

Endocrine Resistance in BC: Mechanisms and Treatment Strategies

University of Kansas Cancer Center Post San Antonio Review

J. Balko

142 views
31:02

Genomic Signatures in Adjuvant Therapy of HR+ EBC: Should We Conside…

University of Kansas Cancer Center Post San Antonio Review

I. Mayer

212 views
27:20

Predictive & Prognostic Biomarkers in Neoadjuvant TNBC: How Valuable…

University of Kansas Cancer Center Post San Antonio Review

A. Bardia

376 views